Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Perkinelmer (PKI)

Perkinelmer (PKI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,872,888
  • Shares Outstanding, K 111,815
  • Annual Sales, $ 2,884 M
  • Annual Income, $ 227,560 K
  • 60-Month Beta 1.30
  • Price/Sales 4.83
  • Price/Cash Flow 19.84
  • Price/Book 4.67
Trade PKI with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.42
  • Number of Estimates 6
  • High Estimate 1.52
  • Low Estimate 1.35
  • Prior Year 1.06
  • Growth Rate Est. (year over year) +33.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
119.94 +5.95%
on 10/15/20
134.39 -5.44%
on 10/12/20
+7.28 (+6.08%)
since 09/25/20
3-Month
111.46 +14.02%
on 08/27/20
134.39 -5.44%
on 10/12/20
+12.11 (+10.53%)
since 07/27/20
52-Week
62.91 +102.00%
on 03/23/20
134.39 -5.44%
on 10/12/20
+40.85 (+47.37%)
since 10/25/19

Most Recent Stories

More News
Should You Buy PerkinElmer (PKI) Ahead of Earnings?

PerkinElmer (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

PKI : 127.08 (+2.43%)
Global Label-Free Detection Markets, 2019-2020 & Forecast to 2025: The Inhibiting Factors and Impact of COVID-19

, /PRNewswire/ -- The report has been added to offering.

AME : 102.59 (-2.39%)
GE : 7.10 (-3.79%)
HICTY : 145.8500 (-1.78%)
HRIBF : 54.4000 (+13.33%)
PKI : 127.08 (+2.43%)
SHMZF : 28.2500 (-2.55%)
PerkinElmer Launches Industry First No-Wash Immunoassay For Phospho Ubiquitin Ser65 to Help Drive Neuroscience Disease and Therapeutics Research Forward

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the life science industry's first no wash Ubiquitin phosphorylation at Serine 65 immunoassay for studying...

PKI : 127.08 (+2.43%)
PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19

PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp(TM) Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30 countries...

PKI : 127.08 (+2.43%)
Is PerkinElmer (PKI) Outperforming Other Computer and Technology Stocks This Year?

Is (PKI) Outperforming Other Computer and Technology Stocks This Year?

PKI : 127.08 (+2.43%)
PerkinElmer Board Declares Quarterly Dividend

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock October 22, 2020. This dividend is payable on February 12, 2021 to all...

PKI : 127.08 (+2.43%)
PerkinElmer (PKI) to Post Q3 Earnings: What's in the Offing?

PerkinElmer's (PKI) third-quarter results are likely to reflect strong performance at Diagnostics segment.

SYK : 213.46 (-0.60%)
MASI : 251.18 (+2.09%)
PKI : 127.08 (+2.43%)
PACB : 14.64 (+4.95%)
Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co

Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co

MMM : 161.03 (-3.09%)
PKI : 127.08 (+2.43%)
SWK : 166.31 (-3.79%)
VRTX : 212.19 (+2.43%)
AJG : 105.57 (-0.56%)
PerkinElmer Immunoassay Helps NIH NCATS Team Identify Therapeutic Compounds Capable of Disrupting the SARS-CoV-2 Spike Protein/ACE2 Interaction

PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that a research team at the National Center for Advancing Translational Sciences (NCATS), an...

PKI : 127.08 (+2.43%)
Bet on These 5 Top-Ranked Stocks With Strong Sales Growth

Robust sales growth is an important characteristic of potential stock market winners. Let's check out - Vertex Pharmaceuticals (VRTX), PerkinElmer (PKI), Stanley Black & Decker (SWK), 3M Company (MMM)...

MMM : 161.03 (-3.09%)
PKI : 127.08 (+2.43%)
SWK : 166.31 (-3.79%)
VRTX : 212.19 (+2.43%)
AJG : 105.57 (-0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Their dedicated team of whole employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical...

See More

Key Turning Points

2nd Resistance Point 131.00
1st Resistance Point 129.04
Last Price 127.08
1st Support Level 124.31
2nd Support Level 121.54

See More

52-Week High 134.39
Last Price 127.08
Fibonacci 61.8% 107.08
Fibonacci 50% 98.65
Fibonacci 38.2% 90.22
52-Week Low 62.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar